Home
Enanta Pharmaceuticals ENTA paid Slaiman Consulting $20K for lobbying in Q3 2023 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $20,000
- Quarter
- Q3 2023
- Client
- Enanta Pharmaceuticals
- Reported
- 23/10/07
$20K on lobbying this year
What else happened in Enanta Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/08/31~23/10/30Enanta Pharmaceuticals's other lobbying reports
- Enanta Pharmaceuticals
LobbyingEnanta Pharmaceuticals
LobbyingEnanta Pharmaceuticals
ENTA
Under $5,000
Under $5,000
Reported 24/01/04
for Q4 2023